ACC Congress 2025 Late-Breaking Science Collection

  • Published:  13 March 2025
  • Views: 

    Views Icon

    2601

  • Likes: 

    Heart Icon

    3

Up Next

ACC Congress 2025 Late-Breaking Science Collection

  • Published:  13 March 2025
  • Views: 

    Views Icon

    2601

  • Likes: 

    Heart Icon

    3

Average (ratings)
No ratings
Your rating
About the episode

Unpack ACC.25's Top Trials with View from the Thoraxcenter!

 

Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC 2025.

 

In this thought-provoking ACC 2025 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions.

 

00:36 - BHF PROTECT TAVI
06:07 - EVOLUT Low Risk
09:17 - TRILUMINATE Pivotal
13:56 - FAME 3
17:50 - ECLIPSE
20:43 - ALTSHOCK II
28:18 - SMART CHOICE 3
31:52 - EKSTROM
34:53 - DAPA TAVI
37:25 - FAIR-HF 2

 

For more content from ACC 2025 head to the Late-breaking Science Video Collection.

Overview

Keep up-to-date with our video collection on the American College of Cardiology's 74th annual congress, covering late-breaking science, featured science and clinical horizon sessions. Don't miss the preview and wrap-up of the congress in our View From the Thoraxcenter series, concise Expert Interviews with select faculty offering take-home messages for practice, and our Highlights summarising the most influential trials.

More from this programme

Faculty Biographies

Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile
Nicolas M Van Mieghem

Nicolas M Van Mieghem

Medical Director

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.